Clinical Trials Browser

Phase 1/2 × Uterine Neoplasms × olaparib × Clear all

NCT01650376 2018-03-23

Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer

Phase 1/2 Unknown

Ovarian Neoplasms, Recurrence, Uterine Neoplasms